The capacity to regulate their internal ionic composition is a fundamental property of free-living terrestrial organisms (Stewari and Broadus, 1987 (Brown et al., 1993 (Reitz et al., 1977 [Nicholson et al., 19771) to induction of seizure-like activity in the cerebellum of an anesthetized rat (Heinemann et al., 1977) , decreases [Ca"], reversibly by anywhere from 20% to as much as 90%. Stimulation of glutamate receptor channels in rat hippocampal pyramidal neurons likewise decreases [Ca2+lo (Stabel et al., 1990) owing to activation of Ca'+ influx through the plasma membrane. The stimulation of cation-nonselective (e.g., NMDA and AMPA/kainate) channels may contribute to concomitant increases in [K+] , and reductions in [Na+] , in this circumstance. The latter can secondarily affect [CaZ+] ,,. For example, decreasing [Na+] , in hippocampal slices from 154 to 114 mM (which also reduces osmolality proportionately) substantially reduces [Ca2+10, probably through a mechanism involving the Na+/Ca'+ exchanger (Chebabo et al., 1995) . The latter effects raise the intriguing possibility that osmosensing in mammalian species could involve, in part, the sensing of osmolality-elicited changes in [CaZ+] ,. There are also large fluxes of Ca*+ into and out of the restricted synaptic space. Synaptic vesicles can contain abundant Ca2+ (up to -10 mmollkg) that is released exocytotically from presynaptic neurons along with neurotransmitters.
Subsequent activation of Cap+-permeable channels on postsynaptic neurons results in a large influx of Ca'+, which could produce substantial reductions in [Ca2+],, within the synaptic cleft.
Like secretory vesicles, the lumen of the endoplasmic reticulum accumulates considerable (millimolar) quantities of Ca*+ that are released by intracellular messengers such as inositol trisphosphate, cytosolic CaZ+ per se, and cyclic ADP-ribose (Bootman and Berridge, 1995) . Could Ca*+ sensors monitor the extent of filling of the endoplasmic reticulum or other membrane-enclosed compartments that accumulate Ca2+, thereby contributing to "spontaneous" release of Ca2+? How Cells Sense [Ca2+], Parathyroid cells and other cell types express a CaR that provides an illustrative example of how specific cells recognize and respond to the [CaZ+10 signal. The CaR recognizes not only [Ca"], and other divalent cations (Mg'+, Ba2+, and ST*+), but also trivalent cations of the lanthanide series (e.g., Cd"+) and even organic polycations such as protamine, polylysine, and neomycin. The surprising promiscuity of the receptor may be of biological significance, as the CaR probably functions as a [Mg*+&, sensor in vivo (see below) and could potentially also recognize other endogenous polycationic ligands present at concentrations appropriate for interacting with the receptor. By Northern blot analysis, the CaR is expressed most abundantly in mammalian parathyroid and kidney but also at lower levels in other tissues, including thyroid (specifically the [Ca2+10-sensing thyroidal C cells), intestine, lung, and various regions of brain (Brown et al., 1993; Ruat et al., 1995) . In parathyroid and C cells, it may represent the principal mediator of [Ca"],-elicited changes in parathyroid hormone (PTH) and calcitonin secretion. It is unclear how the parathyroid cell reverses the usual stimulatory effect of Ca*+ on exocytosis, producing the atypical, inverse relationship between both [Caz+] , and [CaZ++li on the one hand and PTH secretion on the other.
Several inherited diseases of extracellular Ca2+ homeostasis result from CaR mutations, and these "experiments in nature" have provided valuable insights into the normal functions of the receptor. Familial hypocalciuric hypercalcemia (FHH) and neonatal severe hyperparathyroidism (NSHPT) are the phenotypes resulting from inactivating mutations of the receptor when present in the heterozygous and homozygous states, respectively (reviewed by Brown et al., 1995) . It is also clear, however, that mutations in the CaR, which resides on chromosome 3, are not the only genetic basis for the FH H phenotype. A locus on chromosome 19, as well as one linked to neither chromosome 3 nor 19, has also been identified, but the responsible genes have not yet been identified (Heath et al., 1993 ; reviewed by Brown et al., 1995) . Higher than normal concentrations of [Ca"], are present in affected individuals with inactivating CaR mutations, with mild hypercalcemia (-1 O%-20% above the upper limit of normal) in heterozygotes and severe hypercalcemia (1.5-to P-fold elevations in [CaP+] ,) in homozygotes. The hypercalcemia results in large part from a gene dose-dependent "resistance" of the parathyroid glands to [Cap+lO, but affected individuals with FHH and NSHPT also manifest diminished responsiveness to [Ca2+]0 in other tissues. The CaR normally regulates renal tubular reabsorption of CaZ+ in the thick ascending limb of the nephron, with increased levels of [Ca2+], on the basal (i.e., blood) side of the tubule inhibiting Ca2+ reabsorption.
Therefore, the reduced responsiveness of the renal CaR to [Ca*+], in FHH and NSHPT leads to excessive renal tubular Ca'+ reabsorption of CaZ+ ions that contributes to the maintenance of hypercalcemia (Brown et al., 1995) .
The CaR is also present in the renal collecting ducts, where it antagonizes the stimulatory action of vasopressin on water permeability under normal circumstances, presumably through CaR-mediated changes in water channel function or availability in the apical membrane of the collecting duct. Patientswith FHH, on theother hand, concentrate their urine normally despite being hypercalcemic (because of resistance of the collecting duct CaR to [Ca*+],) (Brown et al., 1995) . CaRs in the thick ascending limb and collecting duct, therefore, may function coordinately to balance the homeostatic needs of free-living terrestrial organisms with respect to Ca*+ and water. With Ca2+ excess, the CaR in the thick limb reduces renal tubular CaZ+ reabsorption, resulting in increased urinary Ca*+ loads. If urinary concentration continued unabated, the resultant increase in urinary Ca2+ concentration might cause precipitation of Ca2+-containing salts. Therefore, inhibition of urinary concentrating ability under these circumstances could serve to reduce the risk of kidney stones or tissue CaZ+ deposition.
Patients harboring activating mutations of the CaR, in contrast, exhibit a generally benign form of autosomal dominant hypocalcemia.
In these patients, the CaR has an increased basal (i.e., [Ca'+],-independent) activity, increased affinity for [Ca2+],, or both (reviewed by Brown et al., 1995) , such that the level at which [CaZ+lo is maintained by the homeostatic system is "reset" downward. As might be expected from the preceding discussion on inactivating mutations, some affected individuals with activating mutations show marked increases in renal Ca2+ excretion and impaired urinary concentrating ability as [Ca*+], is increased from its resting hypocalcemic level, presumably because of increased responsiveness of CaRs within the kidney to [Ca2+10.
Several general statements can be made about the functions of the CaR as they relate to maintenance of [Ca2+10 homeostasis (Figure 1) . First, the CaRs in parathyroid cells and C cells sense levels of [Ca2+Jo that reflect systemic Ca2+ homeostasis and adjust calciotropic hormone secretion appropriately to normalize [Ca*+],,. The CaR on renal epithelial cells, on the other hand, senses [Ca2+10 locally within the kidney and modulates the actions of other hormones (e.g., PTH or vasopressin) on solute and water flow to achieve the desired level of [Caz+] , in blood and urine. Second, the polarity of the CaR (e.g., whether it is apical or basal-facing the external or internal environment of the organism, respectively) is critical in determining the compartment in which [Ca2+],, is sensed and the resultant modifications in ion transport, water flow, or other CaR-regulated processes. What is the function of the CaR in tissues that are not involved in systemic [Ca2+],, homeostasis? The CaR in brain is present in several regions, including hippocampus, hypothalamus, and cerebellum, where it may sense local rather than systemic levels of [Ca*+10 (or perhaps some other endogenous CaR ligand) within the brain or cerebrospinal fluid. Ruat et al. (1995) have used immunohistochemistry to localize the CaR to nerve endings, including those on blood vessels. In view of the nerve celldependent changes in [Ca'+],, within the brain discussed above, it is plausible to suggest (Ruat et al., 1995) that the neuronal CaR recognizes and responds to local changes in [Ca2+],, resulting from varying levels of synaptic and neuronal activity. how neuronal CaRs might function depending on their location on the cell. It is intriguing that the CaR is present within the hippocampus, which also contains the metabotropic glutamate receptors (mGluRs), to which the CaR bears a striking similarity in its overall topology (Brown et al., 1993; Nakanishi, 1992) . Did the two receptors arise from a common ancestor by fusion of a "sensing" domain for small charged molecules (which perhaps originated from the bacterial periplasmic binding proteins [Conklin and Bourne, 1993] ), to a serpentine signal-transducing domain? Could the CaR, like the mGluRs, be involved in long-term potentiation and other processes in hippocampal pyramidal neurons related to learning and other cognitive functions?
It seems likely that there are additional forms of CaRs or sensors that mediate the numerous effects of extracellular CaZ+ that have been described on various cell types (reviewed by Brown, 1991) . For instance, elevations in [CaZ+10 reduce PTH gene expression and directly or indirectly inhibit parathyroid cellular proliferation. [Ca*+],, also inhibits osteoclastic bone resorption, in association with changes in [Ca*+li reminiscent of those in parathyroid cells. Furthermore, raising [Ca2+lo inhibits the proliferation and promotes the differentiation of keratinocytes (Hennings et al., 1980) (Smith et al., 1989) . Extracellular phosphate ions regulate the function of bone cells and kidney cells through an unknown mechanism(s). Are there receptors for [Kc] ,, [N?+],, and phosphate ions, either G protein-coupled receptors analogous to the CaR or perhaps distinct forms of receptors regulating a variety of cellular effector systems? Conclusions The cloning of a G-protein-coupled CaR from parathyroid, kidney, and brain and the identification of human diseases resulting from gain-of-function or loss-of-function mutations in the CaR have firmly established that extracellular Ca'+ (and probably Mg2+) can serve as a first messenger. The CaR enables cells to sense changes in [Ca"] , that reflect systemic changes in [Ca*+&, homeostasis (i.e., as sensed by the parathyroid gland), alterations in local cellular activity that are related to mineral ion or water metabolism (e.g., in the kidney), or local cellular functions unrelated to systemic fluid and electrolyte homeostasis (i.e., in the vicinity of brain cells). Further studies may reveal the presence of additional CaRs or sensors that mediate specific, direct actions of extracellular Ca2+ (as opposed to indirect actions due solely to associated changes in [Ca2'li) on particular cell types. Receptors/sensors for other extracellular ions may also exist that represent mechanisms through which various cells recognize the informational content of their local ionic environment and respond in ways that produce autocrine, paracrine, or endocrine/systemic effects on cellular function.
